Why the study?
Does the addition of a nurse practitioner to a multifactorial intervention reduce cardiovascular risk and slow kidney function decline in patients with moderate to severe chronic kidney disease?
RCT (n=793)
Yes
Does the addition of a nurse practitioner to a multifactorial intervention reduce cardiovascular risk and slow kidney function decline in patients with moderate to severe chronic kidney disease?
The MASTERPLAN study is designed to evaluate whether adding nurse practitioners to standard physician care improves cardiovascular risk factor management in patients with moderate to severe chronic kidney disease.
Answers are grounded in this paper and cite their sources.
Near-universal failure to meet all CV risk factor targets in moderate-severe CKD; confirms care gap and supports testing nurse-assisted intervention in MASTERPLAN.
Moderate to severe chronic kidney disease (CKD) is associated with increased cardiovascular risk. Usually nephrologists are primarily responsible for the care of CKD patients. However, in many cases treatment goals, as formulated in guidelines, are not met. The addition of a nurse practitioner might improve the quality of care. The Multifactorial Approach and Superior Treatment Efficacy in Renal Patients with the Aid of Nurse Practitioners (MASTERPLAN) study is a randomized controlled multicenter trial, aimed at investigating whether a multifactorial approach in patients with moderate to severe CKD (stage 3 and 4) to achieving treatment goals using both a polydrug strategy and lifestyle treatment either with or without the addition of a nurse practitioner will reduce cardiovascular risk and slow the decline of kidney function. Patients (n=793) have been randomized to nurse care or physician care. In the nurse-care arm of the study, nurse practitioners use flowcharts to address risk factors requiring drug and/or lifestyle modification. They have been trained to coach patients by motivational interviewing with the aim of improving patient self-management. At baseline, both treatment groups show equal distributions with regard to key variables in the study. Moreover, in only 1 patient were all risk factors within the limits as defined in various guidelines, which underscores the relevance of our initiative.
No takes yet. Share an insight, caveat, or question.
Zuilen et al. (2008) conducted an RCT in Moderate to severe chronic kidney disease (CKD) (n=793). Nurse practitioner-assisted multifactorial care vs. Physician care was evaluated on Cardiovascular risk reduction and slowing of kidney function decline.
Synapse has enriched 10 related papers. Consider them for comparative context: